180 MisawaETanakaMNomaguchiKNabeshimaKYamadaMToidaTet al
Centers for Disease Control and Prevention (CDC)
Given that both SGLT2i and GLP-1 RA demonstrate robust and consistent cardio-renal benefits [14], both agents seem to be an attractive option to fulfil an unmet therapeutic need in type 1 diabetes
According to legal filings and public reports, the severe side effects of Ozempic that were not properly addressed on past warning labels include: Vision loss (caused by NAION, a type of eye stroke) Gastrointestinal issues (e.g., ileus, gastroparesis, and bowel obstructions) Gallbladder problems Pancreatitis Blood clots and deep vein thrombosis Multiple scientific studies have suggested that these side effects, while relatively uncommon, may be more likely to occur if a patient is taking Ozempic or another GLP-1 drug compared to some other common diabetes drugs
Most users inject one right after the other
Regular visits allow for thoughtful adjustments based on progress, symptoms, and data, ensuring care remains safe, responsive, and individualized